References
- Michalska K, Bujacz G, Jaskolski M. Crystal structure of plant asparaginase. J Mol Biol. 2006; 360: 105-116.
- Deb AC. Fundamentals of Biochemistry. New Central Book Agency (P) Ltd. India; 1994.
- National Cancer Institute. NCI Dictionary of Cancer terms. Bethesda MD. 18.03d. 2018. https://www.cancer.gov/publications/dictionaries/cancer-terms Accessed on 20 Jan 2019.
- Konevalova NYu, Buyanova SV. Biochemistry Lecture Course. Ministry of Health of Republic of Belarus Vitebsk State Medical Universite. Vitebsk; 2013. p.163.
- Peterson RE, Ciegler A . L-asparaginase production by various bacteria. Applied Microbiology. 1969; 17(6):929- 930.
- DeJong PJ. L-asparaginase production by Streptomyces griseus. Applied & Environmental Microbiology. 1972; 23 (6):1163-1164.
- Kafkewitz D, Goodman D. L-asparaginase Production by the Rumen Anaerobe Vibrio succinogenes. Applied & Environmental Microbiology. 1974; 27(1): 206-209.
- Sarquis MIdeMoura, Oliveira EMM, Santos AS, da Costa GL. Production of L-asparaginase by filamentous fungi. Memórias do Instituto Oswaldo Cruz. 2004; 99(5): 489-492.
- Cornea CP, Lupescu I, Vatafu I, Caraiani T, Savoiu VG, Campeanu Gh, Grebenisan I, Negulescu Gh.P, Constantinescu D. Production of L-asparaginase II by Recombinant Escherichia coli cells. Roumanian Biotechnology Letters. 2002; 7(3):717-722.
- Mashburn LT, Wriston JC. Tumor inhibitory effect of L asparaginase from Escherichia coli. Arch Biochem Biophys. 1964; 105:450–453.
- Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am. 2008; 55(1):1-20.[PubMed]
- Goekbuget N, Baumann A, Beck J, Boos J, Brueggemann M, Diedrich H. PEG-asparaginase in adult acute lymphoblastic leukemia (ALL): efficacy and feasibility analysis with increasing dose levels. Blood. 2008; 112.
- Savitri, Asthana N, Azmi W. Microbial L-Asparaginase: A potent antitumor enzyme. Indian Journal of Biotechnology. 2003; 2:184-194.
- Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993a; 90(4):pp.1474.
- Dhevagi P, Poorani E . Isolation and characterization of L-Asparaginase from marine Actinomycetes. Indian Journal of Biotechnology. 2006; 5:514-520.
- Capizzi RL, Bertino JR and Skeel RT. L-asparaginase: Clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med. 1971; 74: 893-901.
- Davis BD, Mingioli ES. Mutants of Escherichia coli requiring methionine or vitamin B12. Journal of Bacteriology. 1950; 60(1):17-28.
- Gallagher MP, Marshall RD, Wilson R. Asparaginase as a drug for treatment of acute lymphoblastic leukaemia. Essays Biochemistry. 1989; 24: 1-40.
- Lubkowski J, Dauter M, Aghaiypour K, Wlodawer A, Dauter Z. Atomic Resolution Structure of Erwinia chrysanthemi L-Asparaginase Acta Crystlography D. 2003; 59: 84–92.
- Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v.2. A server for in silico prediction of allergens. J Mol Model. 2014; doi: 10.1007/s00894-014-2278-5. [Epub].
- Geourjon C, Deleage G. SOPMA: Significant Improvements in Protein Secondary Structure Prediction by Consensus Prediction from Multiple Alignments. Comput Appl Biosci. 1995; 11: 681–684.
- Kuntal BK, Aparoy P, Reddanna P . EasyModeller: A graphical interface to MODELLER. BMC Res Notes. 2010; doi: 10.1186/1756-0500-3-226.
- Lovell S C, Davis I W, Arendall III W B, de Bakker P I W, Word JM, Prisant M G, Richardson JS, Richardson D C. . Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins: Structure, Function & Genetics. 2003; 50: 437-450.
- Wallner B., Elofsson A 2003. Protein structure prediction and model quality assessment. Protein Sci. 2003; 112: 1073-1086.
- Shin W H, Lee G R, Heo L, Lee H, Seok C . Prediction of Protein Structure and Interaction by GALAXY protein modeling programs. Bio Design. 2014; 2 (1): 1-11.
- Thompson M A. Molecular docking using ArgusLab, an efficient shape-based search algorithm and the AScore scoring function. ACS meeting, Philadelphia, 172, CINF 42, PA. 2004.
- Wallace, A. C., Laskowski, R. A, Thornton, J. M. LIGPLOT-A program to generate schematic diagrams of protein ligand interactions. Prot. Eng. 1995; 8: 127–134.
- Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson H). Nucl Acids Res. 2005 33(Web Server issue):W363–W367.
- Nocek B, Wu R, Osipiuk J, Moy S, Kim Y, Joachimiak A. Crystal structure of L-asparaginase I from Vibrio cholerae O1 Biovar eltor str. N16961.Midwest Center for Structural Genomics (MCSG). 2006; doi: 10.2210/pdb2OCD/pdb.
- Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. In: Walker JM, editor. The Proteomics Protocols Handbook. Clifton, UK: Humana Press. 2005.
- Chen SH, Yang CY, Chen PF, Setzer D, Tanimura M, Li WH, Gotto AM Jr, Chan L. The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem. 1986; 261:12918-12921.
- Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD. LAsparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J Control Release. 2009; 139 (3):182–9.
- National Cancer Institute. NCI Dictionary of Cancer terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peg-asparaginase Accessed on 01 Sep 2019.
- Yun MK, Nourse A, White SW, Rock CO, Heath RJ. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I. J Mol Biol. 2007; doi:10.1016/j.jmb.2007.03.061.
- Watenpaugh K D, Sieker L C, Jensen L H. Proc Natl Acad Sci USA. 1973; 70: 3857-3860.
- Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993b; 90(4): p. 1477.
- Berg JM, Tymoczko JL, Stryer L. Biochemistry, 7th revised International Edition. W.H. Freeman & Company. 2012.
- Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993c; 90(4): p.1477.
- Reddy ER, Babu RS, Chandrasai PD, Madhuri P. Exploration of the binding modes of l-asparaginase complexed with its amino acid substrates by molecular docking, dynamics and simulation. 3. Biotech. 2016; 6:105.
- Stryer L, Berg JM, Tymoczko JL. “9 Catalytic Strategies”. Biochemistry, 5th edition: San Francisco: W.H. Freeman. 2002. https://en.wikipedia.org/wiki/Catalytic_triad?oldid=745555039Accessed 20 Jan 2019.
- Sanches M, Krauchenco S, Polikarpov I. Structure, Substrate Complexation and Reaction Mechanism of Bacterial Asparaginases. Curr Chem Biol. 2007; 12: 75–86.
- Palm G, Lubkowski J, Derst C, Schleper S, Roehm KH, Wlodawer A. A covalently bound catalytic intermediate in Escherichia coli asparaginase: Crystal structure of a Thr-89-Val mutant. FEBS Lett. 1996; 390: 211-216.
- Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993d; 90(4):p. 1474.
- Derst C, Henseling J, Ro¨hm KH. Engineering the substrate specificity of Escherichia coli asparaginase II. Selective reduction of glutaminase activity by amino acid replacements at position 248. Protein Sci. 2000; 9:2009–2017.